Chemoprophylaxis Is Likely to Be Acceptable and Could Mitigate Syphilis Epidemics Among Populations of Gay Men
Authors:
- David P. WilsonDWDavid P. Wilson
- Garrett P. PrestageGPGarrett P. Prestage
- Richard T. GrayRGRichard T. Gray
- Alexander HoareAHAlexander Hoare
- Pol McCannPMPol McCann
- Ian DownIDIan Down
- Rebecca J. GuyRGRebecca J. Guy
- Fraser DrummondFDFraser Drummond
- Jeffrey D. KlausnerJKJeffrey D. Klausner
- Basil DonovanBDBasil Donovan
- John M. KaldorJKJohn M. Kaldor
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 38 (7) , 573-579
Abstract
Over the last decade, syphilis epidemics have resurged around the world, particularly among gay men. An innovative public health response could be the use of chemoprophylaxis. We sought out to determine the acceptability of syphilis chemoprophylaxis and its likely population effectiveness if it were adopted. We conducted a mixed-methods study. An online survey (n = 2095 participants) and focus groups (n = 23 participants) were conducted to determine whether syphilis chemoprophylaxis is likely to be acceptable to gay men in Australia. We also developed an individual-based mathematical model that simulated a population of gay men, to explore the potential impact of introducing chemoprophylaxis. Of the 2095 gay men surveyed, 52.7% (95% confidence interval, 50.6%-54.8%) indicated that they would be very likely or slightly likely to use chemoprophylaxis to reduce their chance of acquiring syphilis, increasing to 75.8% (95% confidence interval, 74.0%-77.6%) if chemoprophylaxis would help reduce infections in the gay community. In this model, 70% use-effectiveness of chemoprophylaxis used by 50% of gay men is expected to reduce the number of syphilis cases by ∼50% after 12 months and 85% after 10 years. The majority of the prevention efforts can be gained by targeting subpopulations of men with higher sexual activity. Chemoprophylaxis offers promise as an acceptable and effective intervention for mitigating syphilis epidemics. The outcomes of a planned placebo-controlled syphilis chemoprophylaxis trial are eagerly anticipated.Keywords
This publication has 41 references indexed in Scilit:
- Frequent Testing of Highly Sexually Active Gay Men is Required to Control SyphilisSexually Transmitted Diseases, 2010
- Sexually Transmitted Infections in Western Europe Among HIV-Positive Men Who Have Sex With MenSexually Transmitted Diseases, 2007
- High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohortsSexually Transmitted Infections, 2007
- Rising Rates of Syphilis in the Era of Syphilis EliminationSexually Transmitted Diseases, 2007
- Safety of doxycycline and minocycline: A systematic reviewClinical Therapeutics, 2005
- The Acceptability and Behavioral Effects of Antibiotic Prophylaxis for Syphilis PreventionSexually Transmitted Diseases, 2003
- An outbreak no longer: factors contributing to the return of syphilis in Greater ManchesterSexually Transmitted Infections, 2003
- Volunteers in an HIV social care organizationAIDS Care, 1994
- An Efficacy Trial of Doxycycline Chemoprophylaxis against LeptospirosisNew England Journal of Medicine, 1984
- Syphilis in the United StatesSexually Transmitted Diseases, 1983